COR(Cencora, Inc.) 的财务报表:医疗保健,医药分销。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-09-30 | FY 截至 2022-09-30 | FY 截至 2023-09-30 | FY 截至 2024-09-30 | FY 截至 2025-09-30 |
|---|---|---|---|---|---|
| 营业收入 | $213.99B | $238.59B | $262.17B | $293.96B | $321.33B |
| 毛利润 | $6.94B | $8.30B | $8.96B | $9.91B | $11.48B |
| 营业利润 | $2.35B | $2.37B | $2.34B | $2.18B | $2.63B |
| 净利润 | $1.54B | $1.70B | $1.75B | $1.51B | $1.55B |
| 经营现金流 | $2.67B | $2.70B | $3.91B | $3.48B | $3.88B |
| 自由现金流 | $2.23B | $2.21B | $3.45B | $3.00B | $3.21B |
| 摊薄每股收益 | $7.39 | $8.04 | $8.53 | $7.53 | $7.96 |